LI JIANWEI enters ESTRELLA IMMUNOPHARMA, INC. with 1.15M shares across direct and indirect positions
This filing by LI JIANWEI (Chairman and Co-CEO) establishes the baseline for all future Form 4 insider transaction reports at ESTRELLA IMMUNOPHARMA, INC..
Indirect
Filed: 7/22/2021ACC: 0001104659-21-094976
DirectorOfficer10% Owner· Chairman and Co-CEO
Since Jul 2021
1.15M
Baseline shares
0.00
Direct ownership
0 positions
0.00
Derivative underlying
0 instruments
1
Security positions
1.15M indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned1.15M
Total
1.15M indirect1.15M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.15M | Indirect |
| Total | 1.15M | 1.15M indirect |
Derivative Holdings0
No derivative holdings reported